UCB's Global Corporate Website
Welcome to UCB in the United States
  • Healthcare Professionals
  • Patients
  • Investors

    • Categories

    Archives

    Oct

    31

    Bimekizumab Phase 3 Data Shows Superior Skin Clearance Over Humira® in Moderate-to-Severe Psoriasis Patients

    Read More Share:linkedin| twitter| email

    Oct

    29

    UCB Presents Nine Abstracts at EADV 2020, Showcasing Ongoing Commitment to Dermatology

    Read More Share:linkedin| twitter| email

    Oct

    07

    Expanded Relationship with Aetion Advances UCB’s Digital Business Transformation

    UCB and Aetion announced a new agreement to advance UCB’s use of real-world evidence (RWE) using rapid and robust analytics. 

    Read More Share:linkedin| twitter| email

    © 2009 - 2020 UCB, Inc., Atlanta. All rights reserved.
    USPR-CORP-0115-00003(2)